Although less than 12% of current research funding in the life sciences derives from industry, we are witnessing the growth of a multimillion dollar academic-industrial alliance, a venture that brings significant benefit—and misgivings.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Blumenthal, D., Causino, N., Campbell, E. and Louis, K.S. 1996. Relationships between academic institutions and industry in the life sciences—an industry survey. N Engl J Med 334: 368–373.
Stevens, A.J., 1994. University-industry joint ventures. Presentation at Harvard School of Public Health, Boston, November.
Blumenthal, D., 1994. Growing pains for new academic/industry relationships. Health Aff (Millwood) 13(3): 176–193.
Blumenthal, D., Gluck, M., Louis, K.S., Stoto, M.A., and Wise, D. 1986. University-industry research relationships in biotechnology: implications for the university. Science 232: 1361–1366.
Stevens, A.J., 1993. Testimony to US Department of Commerce hearing on the Bayh-Dole Act, Washington, DC, October.
Pressman, L., Guterman, S.K., Abrams, I., Geist, D.E. and Nelsen, L.L., 1995. Pre-production investment and jobs induced by MIT exclusive patent licenses: a preliminary model to measure the economic impact of university licensing. J Assoc University Technology Managers 7: 49–82.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Haber, E. Industry and the university. Nat Biotechnol 14, 441–442 (1996). https://doi.org/10.1038/nbt0496-441
Issue Date:
DOI: https://doi.org/10.1038/nbt0496-441
This article is cited by
-
Minnesota's biotechnology portfolio
Nature Biotechnology (1997)
